LUNAC Therapeutics
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United KingdomWebsite
www.lunactherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About LUNAC Therapeutics
LUNAC Therapeutics is a drug discovery spin-out from the University of Leeds, focused on developing next-generation oral and intravenous anticoagulant therapies aimed at preventing life-threatening thrombotic events without the associated bleeding risks of current treatments. The company targets activated Factor XII (FXIIa), a key enzyme in pathological clot formation, to create first-in-class anticoagulants. With a team of world-leading experts in blood coagulation, LUNAC aims to innovate in the field of anticoagulation therapy. Their intended clients include healthcare providers and patients requiring effective anticoagulation management.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LUNAC Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
LUNAC Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once LUNAC Therapeutics has new funding data
Check out if LUNAC Therapeutics is spiking on competitors!
Earning: See what the market has to say on LUNAC Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if LUNAC Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if LUNAC Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at LUNAC Therapeutics
Product Launch: Get notified when LUNAC Therapeutics launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to LUNAC Therapeutics
Compare insights from companies similar to LUNAC Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
LUNAC Therapeutics
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
LUNAC Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
LUNAC Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about LUNAC Therapeutics.
LUNAC Therapeutics Tech Stack
A closer look at the technologies used by LUNAC Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LUNAC Therapeutics
Sign Up For FreeTo access detailed company insights
LUNAC Therapeutics is a drug discovery spin-out from the University of Leeds, focused on developing next-generation oral and intravenous anticoagulant therapies aimed at preventing life-threatening thrombotic events without the associated bleeding risks of current treatments. The company targets activated Factor XII (FXIIa), a key enzyme in patholo... Read More
